Voluntary Dismissal in Specialty Chemistry Patent Dispute: Liqwd & Olaplex v. L’Oréal USA
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Liqwd, Inc. and Olaplex, LLC v. L’Oréal USA, Inc., et al. |
| Case Number | 1:17-cv-00014-CFC |
| Court | U.S. District Court, District of Delaware |
| Duration | Jan 2017 – Feb 2019 26 months |
| Outcome | Voluntary Dismissal |
| Patents at Issue | |
| Accused Products | L’Oréal Hair Care Products (including Redken lines) |
Case Overview
The Parties
⚖️ Plaintiff
The commercial entities behind the Olaplex hair treatment brand — a disruptive technology in professional and consumer hair care markets built around bond-building chemistry.
🛡️ Defendant
Subsidiaries and affiliates of L’Oréal S.A., one of the world’s largest cosmetics and personal care conglomerates.
The Patent at Issue
This dispute centered on a critical patent covering proprietary hair treatment technology, underpinning a significant competitive advantage in the premium hair treatment segment. The patent’s claims likely address the active chemical mechanisms or application methods that distinguish Olaplex’s bond-protecting treatment approach from conventional hair care products.
- • US Patent No. 9,498,419 — Hair treatment technology broadly categorized within specialty chemistry formulation.
Developing a new chemical formulation?
Ensure your specialty chemistry innovations have freedom-to-operate before product launch.
The Verdict & Legal Analysis
Outcome
The case was terminated by voluntary dismissal, representing a negotiated or unilateral decision to withdraw claims without a court-imposed judgment on the merits. The specific damages amount and any licensing or settlement terms were not publicly disclosed. No injunctive relief was formally adjudicated by the court.
Key Legal Issues
Voluntary dismissal under Federal Rule of Civil Procedure 41 can be initiated by the plaintiff unilaterally or by stipulation of both parties. Given the 783-day duration, this dismissal almost certainly reflects a negotiated resolution — whether a licensing agreement, a cross-license, or a commercial settlement. The timing suggests meaningful discovery and pre-trial activity occurred, shaping settlement leverage. While a voluntary dismissal does not establish binding precedent on claim construction or validity, any Markman hearing briefing or rulings in this matter would have shaped the settlement calculus and provided intelligence on how Delaware courts approach hair-treatment chemistry claims. L’Oréal’s defense team would likely have mounted inter partes review (IPR) petitions or invalidity contentions, which are critical data points for practitioners evaluating the patent’s durability. Given the chemical formulation nature of the patent, any infringement analysis likely grappled with whether L’Oréal’s formulations literally infringed or fell within the doctrine of equivalents.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in specialty chemistry formulation. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View related patents in this technology space
- See which companies are most active in specialty chemistry patents
- Understand claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Bond-building hair treatment chemistry
Related Patents
In hair care formulation space
Design-Around Options
Available for many formulations
✅ Key Takeaways
Voluntary dismissal after 26 months in Delaware typically reflects a negotiated resolution, not weakness — evaluate settlement timing relative to claim construction milestones.
Search related case law →Delaware remains a premium venue for specialty chemistry patent enforcement, offering a sophisticated patent docket.
Explore precedents →Multi-defendant strategies against a conglomerate’s subsidiaries can maximize settlement pressure and overall commercial leverage.
View litigation strategies →Frequently Asked Questions
The case involved U.S. Patent No. 9,498,419, covering hair treatment technology developed by Olaplex.
Voluntary dismissal after 783 days of active litigation typically reflects a negotiated settlement or licensing agreement, though specific terms were not publicly disclosed.
It reinforces that formulation patents can generate significant commercial leverage in litigation, particularly when asserted by market innovators against large industry incumbents.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- U.S. District Court, District of Delaware — Case 1:17-cv-00014-CFC
- U.S. Patent No. 9,498,419 — Hair Treatment Composition
- U.S. Patent and Trademark Office — Patent Search
- Cornell Legal Information Institute — Federal Rule of Civil Procedure 41
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.